[go: up one dir, main page]

MX2009007458A - Biomarcador para la medicina y la biologia de la reproduccion. - Google Patents

Biomarcador para la medicina y la biologia de la reproduccion.

Info

Publication number
MX2009007458A
MX2009007458A MX2009007458A MX2009007458A MX2009007458A MX 2009007458 A MX2009007458 A MX 2009007458A MX 2009007458 A MX2009007458 A MX 2009007458A MX 2009007458 A MX2009007458 A MX 2009007458A MX 2009007458 A MX2009007458 A MX 2009007458A
Authority
MX
Mexico
Prior art keywords
biology
reproduction
medicine
biomarker
ivf
Prior art date
Application number
MX2009007458A
Other languages
English (en)
Inventor
Pascale Paul
Sophie Caillat Zucman
Geraldine Porcu
Original Assignee
Univ Aix Marseille Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aix Marseille Ii filed Critical Univ Aix Marseille Ii
Publication of MX2009007458A publication Critical patent/MX2009007458A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se relaciona con un biomarcador nuevo para la medicina y la biología de reproducción, en particular para el resultado de fertilización in vitro (IVF). Se relaciona con métodos para predecir el resultado de IVF y para seleccionar el sujeto para IVF.
MX2009007458A 2007-01-11 2008-01-11 Biomarcador para la medicina y la biologia de la reproduccion. MX2009007458A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07300720A EP1944611A1 (en) 2007-01-11 2007-01-11 Biomarker for the medicine and the biology of the reproduction
PCT/EP2008/050304 WO2008084105A1 (en) 2007-01-11 2008-01-11 Biomarker for the medicine and the biology of the reproduction

Publications (1)

Publication Number Publication Date
MX2009007458A true MX2009007458A (es) 2009-10-08

Family

ID=38019453

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007458A MX2009007458A (es) 2007-01-11 2008-01-11 Biomarcador para la medicina y la biologia de la reproduccion.

Country Status (9)

Country Link
US (1) US20100112605A1 (es)
EP (2) EP1944611A1 (es)
JP (1) JP5461998B2 (es)
CN (1) CN101641600A (es)
AU (1) AU2008204432B2 (es)
BR (1) BRPI0806302A2 (es)
CA (1) CA2675061A1 (es)
MX (1) MX2009007458A (es)
WO (1) WO2008084105A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458495B2 (en) * 2008-07-01 2016-10-04 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for assessment of clinical infertility
CN102483418B (zh) * 2008-10-31 2015-01-07 耶鲁大学 先兆子痫检测和治疗的方法和组合物
BR112012032761A2 (pt) 2010-06-20 2016-12-20 Univfy Inc método de distribuição de sistemas de suporte de decisão (dss) e registros eletrônicos de saúde (ehr) para tratamentos de cuidado reprodutivo, cuidado pré-conceptivo, fertilidade, e outras condições de saúde.
EP2593788A4 (en) 2010-07-13 2016-08-10 Univfy Inc METHODS OF RISK ASSESSMENT OF MULTILING BIRDS IN THE TREATMENT OF BARRENESS
RU2441243C1 (ru) * 2010-11-12 2012-01-27 Федеральное государственное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования качества эмбриона при проведении эко у женщин с бесплодием
TR201806889T4 (tr) * 2011-08-12 2018-06-21 Artpred B V İn vitro fertilizasyonun tahmin başarısına yönelik yeni yöntem ve kit.
PE20142361A1 (es) * 2011-09-30 2015-01-16 Dana Farber Cancer Inst Inc Peptidos terapeuticos
US9934361B2 (en) 2011-09-30 2018-04-03 Univfy Inc. Method for generating healthcare-related validated prediction models from multiple sources
EA028855B1 (ru) * 2012-08-03 2018-01-31 Ферринг Б.В. Внеклеточная днк в качестве терапевтической мишени для лечения бесплодия у особи женского пола и диагностического маркера
CN103630678A (zh) * 2013-03-29 2014-03-12 中国科学院城市环境研究所 男性不育的生物标志物及其应用
JP6765960B2 (ja) * 2013-06-18 2020-10-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 胚の品質を決定するための方法
EP3161148B1 (en) 2014-06-27 2020-02-12 Institut National de la Sante et de la Recherche Medicale (INSERM) Use of free nucleic acids and microrna in a non-invasive method for determining embryo quality
US10809269B2 (en) 2015-04-21 2020-10-20 Centre Hospitalier Universitaire De Nimes Use of soluble CD146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal
US20190204333A1 (en) * 2015-09-30 2019-07-04 Hudson Institute of Medical Research Method of treatment and prognosis
CN110042156B (zh) * 2019-04-22 2021-12-28 苏州亿康医学检验有限公司 一种判断子宫内膜容受性的方法及其应用
KR20220058977A (ko) 2020-11-02 2022-05-10 김영한 코골이감소 비강확장기
AU2021418225A1 (en) * 2021-01-05 2023-07-13 Public University Corporation Yokohama City University Biomarker for determining fertility, and determining method using same
CN114451358B (zh) * 2022-02-24 2023-03-10 复旦大学附属妇产科医院 一种子痫前期疾病动物模型及其构建方法和应用
CN117647653B (zh) * 2023-12-22 2024-05-07 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） 一种与子痫前期相关的生物标志物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056886A1 (en) * 1998-02-25 2000-12-06 National University of Ireland, Cork Hla linked pre-eclampsia and miscarriage susceptibility gene
EP1578923A4 (en) 2002-04-22 2009-01-21 Hutchinson Fred Cancer Res SOLUBLE MIC POLYPEPTIDE AS A MARKER FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF CANCER AND AUTOIMMUNE DISEASES OR DISEASES
JP2005245294A (ja) * 2004-03-03 2005-09-15 Nipro Corp 体外操作胚の正常性の判定又はスクリーニング方法

Also Published As

Publication number Publication date
BRPI0806302A2 (pt) 2011-09-06
WO2008084105A1 (en) 2008-07-17
EP1944611A1 (en) 2008-07-16
JP5461998B2 (ja) 2014-04-02
CA2675061A1 (en) 2008-07-17
AU2008204432A1 (en) 2008-07-17
JP2010515909A (ja) 2010-05-13
CN101641600A (zh) 2010-02-03
US20100112605A1 (en) 2010-05-06
EP2102662A1 (en) 2009-09-23
AU2008204432B2 (en) 2013-05-16
EP2102662B1 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
MX2009007458A (es) Biomarcador para la medicina y la biologia de la reproduccion.
IN2012DN03012A (es)
MX2010006576A (es) Composiciones y metodos para producir isopreno.
PH12013502230A1 (en) Multispecific antibodies
EP4328589A3 (en) Cancer biomarkers
WO2008091908A3 (en) Human cancer stem cells
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
WO2008070301A3 (en) Predicting lung cancer survival using gene expression
WO2007098150A3 (en) Photobioreactor and uses therefor
GB201021289D0 (en) Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
MX2009003938A (es) Anticuerpos e inmunoconjugados y sus usos.
MX2018013367A (es) Metodos para etiquetar bibliotecas codificadas por adn.
WO2012006447A3 (en) Gene signatures for cancer prognosis
EP2566890A4 (en) ANTI-PAI-1 ANTIBODIES AND METHOD FOR THEIR USE
WO2011112845A3 (en) Methods and compositions related to a multi-methylation assay to predict patient outcome
WO2009055773A3 (en) Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
ZA201000482B (en) Process for the synthesis of e1 activating enzyme inhibitors
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
WO2009055823A3 (en) Method to predict responsiveness of breast cancer to polyaminetype chemotherapy
WO2009149359A3 (en) Survival predictor for diffuse large b cell lymphoma
IN2012DN00852A (es)
WO2012041332A3 (en) Genetic variations in the interleukin-6 receptor gene as predictors of the response to treatment
WO2009088837A3 (en) Methods and products to target, capture and characterize stem cells
TW200825088A (en) Processes for preparing intermediates of pemetrexed
IN2012DN01379A (es)

Legal Events

Date Code Title Description
FG Grant or registration